# Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

> **NCT02584738** · PHASE4 · UNKNOWN · sponsor: **Hospital General Naval de Alta Especialidad - Escuela Medico Naval** · enrollment: 152 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Nebulized Magnesium Sulfate
- **DRUG:** Nebulized isotonic saline
- **DRUG:** Nebulized Salbutamol
- **DRUG:** Ipratropium bromide
- **DRUG:** Methylprednisolone or Prednisolone

## Key facts

- **NCT ID:** NCT02584738
- **Lead sponsor:** Hospital General Naval de Alta Especialidad - Escuela Medico Naval
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-01
- **Final completion:** 2018-01
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584738, "Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02584738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*